During the past decade, LTD "Clinic-LJ" conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LTD "Clinic-LJ"" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "Kowa Research Institute, Inc." with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Destiny Pharma Plc" with 1 trials sponsored and "Institut de Recherches Internationales Servier" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LTD "Clinic-LJ"" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "LTD "Clinic-LJ"" are "Arthritis, Psoriatic" (2 trials), "Severe Hypertriglyceridemia" (2 trials), "Dyslipidemias" (1 trials), "Hypertension" (1 trials) and "Neovascular Age-Related Macular Degeneration" (1 trials). Many other conditions were trialed in "LTD "Clinic-LJ"" in a lesser frequency.

Most popular intervention types in "LTD "Clinic-LJ"" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Fenofibrate" (2 trials), "Guselkumab" (2 trials), "K-877" (2 trials) and "Placebo (for K-877)" (2 trials). Other intervention names were less common.

The vast majority of trials in "LTD "Clinic-LJ"" are 7 trials for "All" genders.

Currently, there are NaN active trials in "LTD "Clinic-LJ"". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in LTD "Clinic-LJ", undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in LTD "Clinic-LJ", 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".